ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,748.40
-0.72%
S&P ASX All Technology
3,079.20
-0.10%
Brent Oil
83.635
0.09%
US Dollar vs AUD
1.51934
-0.08%
Bitcoin
61,466.51
0.46%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Impel Pharmaceuticals Inc (IMPL)

  7. Impel Pharmaceuticals Inc (IMPL) News

IMPL

Impel Pharmaceuticals (IMPL)

Impel Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMPL
DateTimeSourceHeadlineSymbolCompany
10/04/202406:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMPLImpel Pharmaceuticals Inc
16/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMPLImpel Pharmaceuticals Inc
15/02/202409:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMPLImpel Pharmaceuticals Inc
15/02/202409:19Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMPLImpel Pharmaceuticals Inc
15/02/202409:18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:IMPLImpel Pharmaceuticals Inc
15/02/202409:16Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:IMPLImpel Pharmaceuticals Inc
15/02/202409:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
03/01/202408:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
27/12/202308:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMPLImpel Pharmaceuticals Inc
19/12/202300:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
04/12/202322:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
15/11/202308:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
03/11/202308:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
17/10/202307:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
06/10/202308:19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMPLImpel Pharmaceuticals Inc
05/10/202323:00GlobeNewswire Inc.Impel Pharmaceuticals Announces Exploration of Strategic AlternativesNASDAQ:IMPLImpel Pharmaceuticals Inc
05/10/202308:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
19/09/202311:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
08/09/202306:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
21/08/202322:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMPLImpel Pharmaceuticals Inc
18/08/202323:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMPLImpel Pharmaceuticals Inc
16/08/202306:29Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:IMPLImpel Pharmaceuticals Inc
06/07/202300:05AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202320:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202320:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202320:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202320:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
21/06/202320:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
15/06/202322:00GlobeNewswire Inc.Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache SocietyNASDAQ:IMPLImpel Pharmaceuticals Inc
13/05/202306:23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMPLImpel Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IMPL

Your Recent History

ASX
WES
Wesfarmers
CCOM
SILVER
SILVER
NYSE
DIS
Walt Disney
ASX
RIO
Rio Tinto
ASX
NCM
Newcrest Mining
NASDAQ
GOOGL
Alphabet
ASX
WDC
Westfield
NYSE
NKE
Nike
NYSE
KO
Coca Cola
ASX
XJO
S&P ASX 200
FX
AUDCAD
AUD vs CAD
ASX
QBE
QBE Insurance
COIN
ETHUSD
Ethereum
ASX
NAB
National Australia Bank
ASX
CSL
CSL
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved